Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Medivir licenses MIV-150 to Population Council

Aug. 4, 2003

Spirodiketopiperazine CCR5 antagonist enters the clinic as a potential new anti-HIV agent

Aug. 1, 2003

AVX-101 enters clinic

July 31, 2003

Clinical trial results for emtricitabine discussed at HIV meeting

July 30, 2003

European approval recommended for Emtriva

July 29, 2003

Preliminary 48-week data from CONTEXT study

July 28, 2003

Third-generation protease inhibitor active against wild-type and resistant HIV

July 28, 2003

Atazanavir-containing regimens in the management of HIV-1 infection

July 25, 2003

UMass team discovers small-molecule inhibitors of Tat-TAR with anti-HIV activity

July 24, 2003

Tipranavir/ritonavir combination therapy in HIV infection

July 23, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...